2009 - Review: Differences in efficacy and acceptability exist for 12 new-generation antidepressants for major depression

Usherwood, Tim
July 2009
ACP Journal Club;7/21/2009, Vol. 151 Issue 1, p8
Academic Journal
The article focuses on a study of the relative efficacy of 12 new-generation antidepressants for relieving major depression. The study was conducted through randomized controlled trials (RCTs). The study concluded that new-generation antidepressants differ in efficacy and acceptability in patients with major depression.


Related Articles

  • What Shapes Depressed Individuals' Pre-Treatment Expectation in Antidepressant Clinical Trials? Moses, Tally; Leuchter, Andrew F.; Cook, Ian; Abrams, Michelle // Internet Journal of Mental Health;2007, Vol. 3 Issue 2, p2 

    Objective: To examine the relationship between patients' treatment outcome expectation and a set of socio-demographic factors, clinical course variables, symptom severity, health locus of control, and Temperament and Character Inventory (TCI) dimensions. Method: Logistic regression analyses were...

  • Antidepressants a Concern in Young Patients.  // Nutrition Health Review: The Consumer's Medical Journal;2003, Issue 88, p14 

    Health authorities have warned patients taking antidepressants, including children and teenagers, that signs of worsening depression and suicidal thoughts should be monitored. The warning comes after a panel of experts in February 2004 called on the U.S. FDA to issue stronger warnings to...

  • Which class of antidepressants is most effective and best tolerated by patients with major depression? Sparano, Nicole // Journal of Family Practice;Oct2000, Vol. 49 Issue 10, p886 

    The article examines the classes of antidepressants that are effective and tolerated by patients with major depression. In 1993 the Agency for Health Care Policy and Research published guidelines for the treatment of major depression that focused on the efficacy of older antidepressants,...

  • Antidepressants and adverse effects in young patients: uncovering the evidence. Herxheimer, Andrew; Mintzes, Barbara // CMAJ: Canadian Medical Association Journal;2/17/2004, Vol. 170 Issue 4, p487 

    Addresses the need for premarket clinical trials of antidepressants in order to determine their efficiency and the harmful effects they may have on young patients. Warning against the use of selective serotonin reuptake inhibitors; Duration of most randomized trials of antidepressants; Value of...

  • The effect of forewarning on the occurrence of side-effects and discontinuance of medication in patients on amitriptyline. Myers, E. D.; Calvert, E. J. // British Journal of Psychiatry;Apr73, Vol. 122 Issue 569, p461 

    The article discusses the study on the impact of prevising patients taking amitriptyline on its side-effects. It is believed that psychological factors are significant in identifying the harmful or good effects of drugs. In an amitriptyline trial, patients were asked to note down their...

  • Patient Engagement Programs for Recognition and Initial Treatment of Depression in Primary Care. Kravitz, Richard L.; Franks, Peter; Feldman, Mitchell D.; Tancredi, Daniel J.; Slee, Christina A.; Epstein, Ronald M.; Duberstein, Paul R.; Bell, Robert A.; Jackson-Triche, Maga; Paterniti, Debora A.; Cipri, Camille; Iosif, Ana-Maria; Olson, Sarah; Kelly-Reif, Steven; Hudnut, Andrew; Dvorak, Simon; Turner, Charles; Jerant, Anthony // JAMA: Journal of the American Medical Association;11/6/2013, Vol. 310 Issue 17, p1818 

    IMPORTANCE Encouraging primary care patients to address depression symptoms and care with clinicians could improve outcomes but may also result in unnecessary treatment. OBJECTIVE TO determine whether a depression engagement video (DEV) or a tailored interactive multimedia computer program...

  • The effect of adalimumab on reducing depression symptoms in patients with moderate-to-severe psoriasis: a randomized clinical trial.  // Advances in Psoriasis & Inflammatory Skin Diseases;2010, Vol. 2 Issue 1, p25 

    The article presents the randomized clinical trial on the effect of adalimumab on the reduction of depression symptoms in patients suffering moderate-to-severe psoriasis. The study shows the association of psoriasis with increased rates of emotional and psychological disorders and impaired...

  • Depression in glioma: a primer for clinicians and researchers. Rooney, Alasdair G.; Brown, Paul D.; Reijneveld, Jacob C.; Grant, Robin // Journal of Neurology, Neurosurgery & Psychiatry;Feb2014, Vol. 85 Issue 2, p230 

    Depression is one of the leading causes of global disability, and a considerable hidden morbidity among patients with glioma. In this narrative review, we summarise what is currently known about depression in glioma, the main unanswered questions and the types of studies that should be...

  • Escitalopram: In the Treatment of Major Depressive Disorder in Adolescent Patients. Lily P.H. Yang; Scott, Lesley J. // Pediatric Drugs;2010, Vol. 12 Issue 3, p155 

    Escitalopram is a selective serotonin reuptake inhibitor (SSRI), and is the second antidepressant to be approved for use in treating major depressive disorder (MDD) in adolescent patients (aged 12-17 years) in the US. In a randomized, double-blind, flexible-dose, multicenter trial, once-daily...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics